Business Context and Reporting Period
Company: Perma-Fix Environmental Services, Inc. (PESI)
Filing Type: Form 8-K (Current Report)
Date of Report: May 14, 2026
Reporting Period: Event-based filing regarding a material definitive agreement and public offering.
Key Financial Metrics and Transaction Details
This filing details a firm commitment underwritten public offering rather than periodic financial results. Key transaction metrics include:
- Shares Sold: 2,285,714 shares initially, plus 342,857 shares via full exercise of the over-allotment option (Total: 2,628,571 shares).
- Offering Price: $8.75 per share.
- Net Proceeds: Approximately $21,094,997 (after underwriting discounts, commissions, and estimated expenses).
- Underwriter: Craig-Hallum Capital Group LLC.
- Expected Closing Date: On or about May 18, 2026.
Note: The filing does not provide current revenue, profit, cash flow, margins, debt, or liquidity figures. Investors should refer to the most recent Form 10-K or 10-Q for operational financial data.
Material Changes and Use of Proceeds
The primary material change is the entry into an underwriting agreement to raise capital. The Company plans to use the net proceeds for the following specific purposes:
- Funding costs for Direct-Feed Low-Activity Waste and grouting upgrades at the Perma-Fix Northwest Richland facility.
- Research and development and business development for the patent-pending Perma-FAS process for PFAS destruction.
- Completion of the installation of the Perma-FAS Gen 2.0 commercial treatment unit.
- Ongoing facility capital expenditures and maintenance costs.
- General corporate and working capital purposes.
Guidance, Outlook, and Risks
Management Commentary and Outlook: The Company anticipates a step-up in activity beginning in the second quarter of 2026. Key growth drivers mentioned include opportunities at Hanford, Nuclear Services, and PFAS destruction. Management expects to convert a multi-year investment cycle into improved operating performance through the balance of 2026. Specific mentions include expanding treatment capacity at Perma-Fix Northwest and the value of the contract with Lawrence Livermore National Laboratory.
Risks and Contingencies: Forward-looking statements are subject to significant risks, including:
- Quarterly variability in the timing of government programs and customer shipments.
- Failure of government parties (DOD/DOE) to provide funding or comply with contracts.
- Termination of existing contracts or failure to obtain new domestic and foreign remediation contracts.
- Market acceptance of new technologies (Perma-FAS).
- General economic and competitive pressures.
Investor Verification Checklist
- Verify the final closing of the offering and the actual net proceeds received on or after May 18, 2026.
- Review the most recent Form 10-Q (ended March 31, 2026) and Form 10-K (2025) for current liquidity, debt levels, and operating cash flow.
- Monitor the progress of the Perma-FAS Gen 2.0 commercial treatment unit installation and the Richland facility upgrades.
- Assess the status of government funding for DOD and DOE remediation projects referenced in the risk factors.
- Confirm the execution of the over-allotment option (noted as exercised in full on May 15, 2026) and the final share count.